Literature DB >> 1793218

Protein engineering of DAB-IL-2 fusion toxins to increase biologic potency.

T Kiyokawa1, D P Williams, C E Snider, C A Waters, J C Nichols, T B Strom, J R Murphy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793218     DOI: 10.1111/j.1749-6632.1991.tb33463.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  1 in total

1.  Immunogenic and tolerogenic effects of the chimeric IL-2-diphtheria toxin cytocidal agent Ontak® on CD25+ cells.

Authors:  Manfred B Lutz; Andreas S Baur; Beatrice Schuler-Thurner; Gerold Schuler
Journal:  Oncoimmunology       Date:  2014-03-17       Impact factor: 8.110

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.